BeHealth

Who we are

Who we are

Be Health is an innovative company specialized in the marketing of high-quality nutraceutical and cosmeceutical products, designed to improve people’s well-being. Our focus is to offer scientifically advanced solutions to support personal health and care, through products formulated with natural ingredients, innovative active principles, and tested with the most modern technologies.

We aim to progressively acquire a distinctive position in the market. We intend to pursue this goal in various ways: by launching products with a unique positioning in their category and by developing a leadership culture that involves taking care of our Human Capital.
Be Health is also active in providing assistance in formulation development, product analysis and market trends, raw material sourcing, safety and efficacy assessment, regulatory and technical support in Italy and abroad, and logistics services.

We operate with a distribution model based on network marketing, an approach that enhances the direct relationship between the brand and consumers, offering our sales representatives a personal entrepreneurial opportunity based on trust and the shared benefits of our products.

BeHealth

The science

THE SCIENCE OF COLLAGEN SINCE 1985

1985
1990
2000
2007
2008
2010
2015
2015
2017
2017
2019
2019
First clinical use of hydrolyzed collagen in disorders of the hair system.
Experimental study demonstrating that hydrolyzed collagen at appropriate doses and treatment durations induces increased hair growth in men.
First to consider the use of partially hydrolyzed collagen as a dietary supplement.
Topical role of hydrolyzed collagen as a biological material that protects the body as a natural barrier and then nourishes tissues.
SBM - Science of Biology in Medicine – is founded by Prof. Silvestrini, a scientist with over 50 years of experience in pharmacological research. A company dedicated to pure research.
Serendipitous discovery of the role of collagen in xerophthalmia.
SBM Trading Srl is established to provide a first commercial outlet for research conducted by SBM Srl.
An absolute innovation: the bone acidostat to regulate harmful gastric acidity peaks.
Discovery of collagen as a controlled-release drug delivery system for topical use.
Health Italia SpA recognizes the potential – acquiring 51% of both companies – and initiates a major corporate restructuring process that concludes in December 2018 with the merger of SBM Trading into SBM Srl and the renaming of the latter to Health Pharma Srl.
The scientific community recognizes a new nosographic entity: collagen deficiency disease.
Health Pharma becomes a Joint-Stock Company.

BeHealth

Ricerca

Research

Our science is based on the observation of physiological phenomena underlying the body’s functions. Scientific rigor in research is and will always be the foundation of our work, with the goal of offering our commercial network and end users products rich in distinctive intrinsic value.

We constantly seek collaboration with universities, hospitals, and research institutes to support our studies and provide further objective evidence of the value of our products.

One of our major experimental areas is deficiency collagenopathy.

THE SCIENTIFIC BOARD

Be Health’s primary development goals are the progressive expansion of the indications for use of existing products and the extension of the offering into other therapeutic areas.

To implement these objectives, Be Health relies on a series of collaborations with field experts as well as highly valuable manufacturing partners.

THE UNIVERSAL PROTEIN

Studies on collagen and pathologies related to its deficiency are the result of over 30 years of research, which saw us among the first to understand the importance of this protein for the human body. Be Health is a leader in the development of collagen-based products that serve as effective adjuvants in the treatment of conditions affecting not only the skin appendages, but especially the osteoarticular system, the digestive system, and the mucous membranes.

WHAT IT IS

The term collagen refers to a family of proteins that span the entire body, connecting its parts and performing specific physiological roles.

ITS STRUCTURE

It has a fibrous conformation consisting of three polypeptide chains forming a triple helix.

ITS PROPERTIES

Collagen has two biological properties: a mechanical effect, of support and protection, and a trophic effect.

DEFICIENCY COLLAGENOPATHY

Collagen undergoes a continuous loss, associated with an equally continuous regeneration process. Collagenopathy results from the dominance of this loss over regeneration. Deficiency collagenopathy presents with dystrophic and degenerative characteristics, such as osteoporosis, osteoarthritis, and gastric and skin ulcers.

THE SOLUTION

The solution is offered by hydrolyzed collagen, bioavailable, safe, and with documented efficacy in preclinical and clinical studies.

In addition to oral administration, hydrolyzed collagen also exhibits its biological effects when applied topically: for example, when applied to skin wounds, it promotes granulation and healing.

The systemic dosage is about 100 mg/Kg/day, in line with the daily loss of the protein. For topical uses, the dosage is variable and much lower. To be effective, treatment requires 1 to 6 months, depending on the severity of the condition and the area involved.

THE COLLAGEN COMPANY

Company profile

OVERVIEW

Be Health Spa is a company that sells nutraceutical and cosmeceutical products using the network marketing distribution method.

The company was founded in 2018 and aims to improve people’s well-being through the use of its products and distribution system.

1.117
ACTIVE REPRESENTATIVES

28.973
CUSTOMERS

Donut chart showing revenue split: 58% from customers (red), 42% from representatives (blue).

A Representative is someone who has chosen not only to purchase Be Health products but also to promote them by building a sales network and through word of mouth, receiving a commission based on final customer sales.

Customers, on the other hand, are those who choose to use the products without promoting them to others and therefore do not receive any reward for word of mouth.

Bar chart showing yearly order count from 2020 to 2024: highest total in 2024 with 10,192 representative orders and 5,620 customer orders.

BUSINESS

Be Health: A New Business Model for Wellness and Health

WHO WE ARE AND WHAT WE DO

Be Health is an innovative company specializing in the marketing of high-quality nutraceutical and cosmeceutical products, designed to improve people’s well-being. Our focus is on offering scientifically advanced solutions to support health and personal care, through products formulated with natural ingredients, innovative active compounds, and tested using the most modern technologies.

We operate through a distribution model based on network marketing—an approach that values the direct relationship between the brand and consumers. It offers our sales representatives a personal entrepreneurial opportunity, grounded in trust and in sharing the benefits of our products.

THE DISTRIBUTION METHOD

Our business model is based on a strategic mix of:

NETWORK MARKETING

A direct sales system that allows our representatives (the Be Healthers) to earn through product sales and the development of a network of collaborators. This model enables the creation of a widespread and loyal network.

ONLINE CHANNELS

We use e-commerce platforms, social media, webinars, and digital campaigns to promote our products and reach new customers. This online strategy allows for rapid scaling and provides a direct and intuitive shopping experience.

OFFLINE CHANNELS

Events, training meetings, workshops, and live presentations are key tools for strengthening the sales network, educating customers on the benefits of our products, and building a strong sense of community.

Thanks to this combination, Be Health is able to maintain a solid market presence and constant interaction with customers, maximizing the effectiveness of its commercial strategy.

MILESTONES

2008
SBM Srl is founded based on the studies of Prof. Silvestrini on collagen.
2008
2009
Physio Didaktika is established, owner of the Dolomitika brand, a cosmetics company.
2009
2016
SBM Trading is created for online sales.
2016
2018
SBM Srl incorporates SBM Trading and becomes HEALTH PHARMA.
Be Live Spa is founded.
2018
2019
HEALTH PHARMA begins a partnership with Physio Didaktika.
Patent validated for Gadirel Italy (AE-40678).
2019
2020
Be Live acquires Health for Life SpA (sales network) and Biorei Srl, specialized in reishi mushroom.
Be Live changes its name to BE HEALTH.
2020
2021
Be Health acquires Health Pharma.
2021
2023
Be Health acquires the commercial network of House to House.
2023
2024
Expansion into foreign markets.
2024
2025
New shareholders enter the capital with an Aucap.
2025

Context and Reference Data

Bar chart showing 2023 direct sales in Europe and in the world.

Some data to report for the first 9 months of 2024 in the network sector in Italy:

4,72%

Growth of the sector
compared to 2023 in the first 9 months (Avedisco data)

68%

Growth of Be Health
compared to 2023 (89.1% compared to the first 9 months of 2023). Over 270,000 representatives

i dati fanno riferimento alle vendite in tutti i settori effettuati tramite il Network Marketing e la vendita diretta

TERRITORIAL PRESENCE

OUR EXPANSION

Be Health has achieved significant positioning not only in Italy, where it is present in all 20 regions, but also in several European countries including:

This expansion is the result of a scalable model and a growth strategy
based on three fundamental pillars:

Training and support for Be Healthers to help them develop their own network of customers and collaborators.

Adaptation to local markets, with targeted strategies for each country.

A competitive product offering, with formulas designed to meet the specific needs of different markets

BUSINESS

VISION AND VALUES

Be Health is not just a company that sells health products, but a true
movement that places the concept of well-being at its core as a mission.

Our philosophy is based on key values such as:

Thanks to this combination of factors, Be Health continues to grow, strengthening its presence in European markets and creating an innovative and sustainable business model.

Customers and Sales Channels

Bar chart showing customer, order, and revenue growth from 2020 to 2024, with revenue as the highest metric in 2024.

STRATEGY

TARGETED INTERNATIONAL EXPANSION

Be Health has already established a strong presence in all 20 Italian regions and has successfully begun its expansion into foreign markets, with sales in:

International expansion is a key element to increase brand awareness and market share in the nutraceutical and cosmeceutical sector.

FOREIGN MARKET ENTRY STRATEGY

Competitive Advantage:
A structured and progressive expansion that reduces entry risks and maximizes success in new markets.

DIFFERENTIATION AND POSITIONING IN THE COLLAGEN MARKET

A key strategic asset for Be Health’s growth is vertical integration in collagen and the exclusive patent approved by the U.S. FDA. This allows us to differentiate ourselves from competitors with a unique and scientifically validated offering.

Strategies for Consolidation in the Collagen Segment:

Competitive Advantage:
Reinforce our leadership in the collagen market through a premium and differentiated positioning.

KEY SUCCESS FACTORS

The success of Be Health is the result of a combination of strategic elements that allow us to grow and consolidate in the nutraceutical and cosmeceutical market through network marketing. Here are the main Key Success Factors (KSF) that determine the company’s competitive advantage.

PRODUCT QUALITY AND INNOVATION

Competitive Advantage::
A premium positioning with products perceived as high-value, increasing customer loyalty.

One of the fundamental pillars of Be Health’s success is the superiority of our offering. The nutraceutical and cosmeceutical market is highly competitive, and only products with strong scientific validation and proven efficacy can earn consumers’ trust.

COLLAGEN VERTICALIZATION AND FDA-APPROVED PATENT

Competitive Advantage:
FDA approval provides scientific credibility and a distinctive value, strengthening market trust and increasing the entry barrier for competitors.

A distinctive element of Be Health is the specialization in collagen, a rapidly growing segment in the nutraceutical and cosmeceutical sector.

OMNICHANNEL STRATEGY: NETWORK MARKETING + DIGITAL

Competitive Advantage:
A scalable system that combines the power of human relationships with the efficiency of digital automation.

Our hybrid distribution model combines the power of network marketing with the opportunities offered by digital tools. This approach allows us to maximize market penetration and the acquisition of new customers.

TRAINING AND SUPPORT FOR THE SALES NETWORK (BE HEALTHERS)

Competitive Advantage:
A more competent and motivated sales network, with a low dropout rate and sustainable growth.

Network marketing only works if the sales representatives are well-trained and motivated. Be Health invests significantly in education, coaching, and mentorship, providing practical tools for success.

INTERNATIONAL EXPANSION AND SCALABILITY

Competitive Advantage:
A growth model replicable in new markets, with continuous and sustainable geographic expansion.

Be Health has adopted a targeted and structured international growth strategy, successfully entering various European markets.

MISSION AND VALUES: HEALTH AS A BUSINESS DRIVER

Competitive Advantage:
Trust and brand identification lead to greater customer and sales representative retention.

One of the main reasons why Be Health is succeeding is that it does not simply sell
products but has a clear mission and a high perceived value.

CONCLUSIONS

The Key Success Factors of Be Health are the result of a winning strategy that combines:

Thanks to these elements, Be Health is consolidating its position as a leader in the European
nutraceutical and cosmeceutical market, with a sustainable and continuously growing
business model.

SHAREHOLDING AND GOVERNANCE

Donut chart of shareholder distribution: BASIS SPA (317,205), FEDERICO PAGANUCCI (69,939), followed by smaller holders including MUTUA MBA, SORGIVA HOLDING, AZIMUT, PFH SRL, and others.

Management

FINANCIALS

Line chart of taxable revenue from 2020 to 2024, with a dip in 2022 and strong growth to €1.7M in 2024.
Donut chart showing 2024 product category split: Nutraceuticals 85%, Cosmeceuticals 7%, Pastry Low Carb 3%, Services 3%, Home Care 1%.
Bar chart of gross margin percentages in 2024: Laundry Products lead at 40%, others range between 26% and 35%.
Bar chart showing 2024 gross margin and revenue: Collagen for Life and Alchemy have the highest values; others remain low.
Panoramica privacy

Questo sito web utilizza i cookie per consentirci di offrirti la migliore esperienza utente possibile. Le informazioni sui cookie sono memorizzate nel tuo browser ed eseguono funzioni come riconoscerti quando ritorni sul nostro sito web e aiutare il nostro team a capire quali sezioni del sito web trovi più interessanti e utili.